Taste alterations and oral discomfort in patients receiving chemotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Taste alterations and oral discomfort in patients receiving chemotherapy. / Larsen, Anne Kathrine; Thomsen, Christine; Sanden, Mathilde; Skadhauge, Lotte Boa; Anker, Camilla Bundgaard; Mortensen, Marie Nerup; Bredie, Wender L. P.

In: Supportive Care in Cancer, Vol. 29, 2021, p. 7431–7439.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Larsen, AK, Thomsen, C, Sanden, M, Skadhauge, LB, Anker, CB, Mortensen, MN & Bredie, WLP 2021, 'Taste alterations and oral discomfort in patients receiving chemotherapy', Supportive Care in Cancer, vol. 29, pp. 7431–7439. https://doi.org/10.1007/s00520-021-06316-4

APA

Larsen, A. K., Thomsen, C., Sanden, M., Skadhauge, L. B., Anker, C. B., Mortensen, M. N., & Bredie, W. L. P. (2021). Taste alterations and oral discomfort in patients receiving chemotherapy. Supportive Care in Cancer, 29, 7431–7439. https://doi.org/10.1007/s00520-021-06316-4

Vancouver

Larsen AK, Thomsen C, Sanden M, Skadhauge LB, Anker CB, Mortensen MN et al. Taste alterations and oral discomfort in patients receiving chemotherapy. Supportive Care in Cancer. 2021;29:7431–7439. https://doi.org/10.1007/s00520-021-06316-4

Author

Larsen, Anne Kathrine ; Thomsen, Christine ; Sanden, Mathilde ; Skadhauge, Lotte Boa ; Anker, Camilla Bundgaard ; Mortensen, Marie Nerup ; Bredie, Wender L. P. / Taste alterations and oral discomfort in patients receiving chemotherapy. In: Supportive Care in Cancer. 2021 ; Vol. 29. pp. 7431–7439.

Bibtex

@article{fa30f142ff2e4c7b8e12929d8fa6767e,
title = "Taste alterations and oral discomfort in patients receiving chemotherapy",
abstract = "Purpose: Taste alterations (TA) and oral discomfort in cancer patients are neglected side effects of the disease and treatments. They contribute to poor appetite, decrease food intake and affect quality of life, leading to adverse outcomes such as malnutrition and depression. The study aimed to explore TAs in relation to other oral conditions causing discomfort in cancer patients. Additionally, the correlation between patients{\textquoteright} acidity of saliva and experienced TAs and oral discomfort was evaluated. Methods: A case study including 100 patients diagnosed with cancer receiving chemotherapy or immunotherapy. Data were collected using two questionnaire forms: the Chemotherapy-induced Taste Alteration Scale (CiTAS) and an additional information questionnaire. Saliva samples were collected for each patient and measured with a pocket pH meter. Data were analysed using descriptive statistics, and comparisons were performed using the Kruskal–Wallis H test, Mann–Whitney U test and Fisher{\textquoteright}s exact test. Results: The prevalence of reported TAs was 93%. Patient age, oral discomfort and swallowing difficulty were found to be significant factors for experienced TAs (p < 0.05). No correlation between patients{\textquoteright} acidity of saliva and reported TAs and oral discomfort was found. Conclusion: CiTAS proved to be a convenient tool to collect information about TAs in cancer patients. Using the CiTAS tool, a high prevalence (93%) of reported TAs in cancer patients receiving chemo- or immunotherapy was found. CiTAS provides a fast and cheap recognition of symptoms and causes of TAs that can be addressed.",
keywords = "Acidity, Cancer, Chemotherapy, CiTAS, PH, Saliva, Taste alterations",
author = "Larsen, {Anne Kathrine} and Christine Thomsen and Mathilde Sanden and Skadhauge, {Lotte Boa} and Anker, {Camilla Bundgaard} and Mortensen, {Marie Nerup} and Bredie, {Wender L. P.}",
note = "Funding Information: This work was financially supported by the Innovationsfonden (Denmark). Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2021",
doi = "10.1007/s00520-021-06316-4",
language = "English",
volume = "29",
pages = "7431–7439",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Taste alterations and oral discomfort in patients receiving chemotherapy

AU - Larsen, Anne Kathrine

AU - Thomsen, Christine

AU - Sanden, Mathilde

AU - Skadhauge, Lotte Boa

AU - Anker, Camilla Bundgaard

AU - Mortensen, Marie Nerup

AU - Bredie, Wender L. P.

N1 - Funding Information: This work was financially supported by the Innovationsfonden (Denmark). Publisher Copyright: © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2021

Y1 - 2021

N2 - Purpose: Taste alterations (TA) and oral discomfort in cancer patients are neglected side effects of the disease and treatments. They contribute to poor appetite, decrease food intake and affect quality of life, leading to adverse outcomes such as malnutrition and depression. The study aimed to explore TAs in relation to other oral conditions causing discomfort in cancer patients. Additionally, the correlation between patients’ acidity of saliva and experienced TAs and oral discomfort was evaluated. Methods: A case study including 100 patients diagnosed with cancer receiving chemotherapy or immunotherapy. Data were collected using two questionnaire forms: the Chemotherapy-induced Taste Alteration Scale (CiTAS) and an additional information questionnaire. Saliva samples were collected for each patient and measured with a pocket pH meter. Data were analysed using descriptive statistics, and comparisons were performed using the Kruskal–Wallis H test, Mann–Whitney U test and Fisher’s exact test. Results: The prevalence of reported TAs was 93%. Patient age, oral discomfort and swallowing difficulty were found to be significant factors for experienced TAs (p < 0.05). No correlation between patients’ acidity of saliva and reported TAs and oral discomfort was found. Conclusion: CiTAS proved to be a convenient tool to collect information about TAs in cancer patients. Using the CiTAS tool, a high prevalence (93%) of reported TAs in cancer patients receiving chemo- or immunotherapy was found. CiTAS provides a fast and cheap recognition of symptoms and causes of TAs that can be addressed.

AB - Purpose: Taste alterations (TA) and oral discomfort in cancer patients are neglected side effects of the disease and treatments. They contribute to poor appetite, decrease food intake and affect quality of life, leading to adverse outcomes such as malnutrition and depression. The study aimed to explore TAs in relation to other oral conditions causing discomfort in cancer patients. Additionally, the correlation between patients’ acidity of saliva and experienced TAs and oral discomfort was evaluated. Methods: A case study including 100 patients diagnosed with cancer receiving chemotherapy or immunotherapy. Data were collected using two questionnaire forms: the Chemotherapy-induced Taste Alteration Scale (CiTAS) and an additional information questionnaire. Saliva samples were collected for each patient and measured with a pocket pH meter. Data were analysed using descriptive statistics, and comparisons were performed using the Kruskal–Wallis H test, Mann–Whitney U test and Fisher’s exact test. Results: The prevalence of reported TAs was 93%. Patient age, oral discomfort and swallowing difficulty were found to be significant factors for experienced TAs (p < 0.05). No correlation between patients’ acidity of saliva and reported TAs and oral discomfort was found. Conclusion: CiTAS proved to be a convenient tool to collect information about TAs in cancer patients. Using the CiTAS tool, a high prevalence (93%) of reported TAs in cancer patients receiving chemo- or immunotherapy was found. CiTAS provides a fast and cheap recognition of symptoms and causes of TAs that can be addressed.

KW - Acidity

KW - Cancer

KW - Chemotherapy

KW - CiTAS

KW - PH

KW - Saliva

KW - Taste alterations

U2 - 10.1007/s00520-021-06316-4

DO - 10.1007/s00520-021-06316-4

M3 - Journal article

C2 - 34080053

AN - SCOPUS:85107428580

VL - 29

SP - 7431

EP - 7439

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -

ID: 272500101